Heart Disease - Estimating Your RiskNovember 27, 2003Current methods used by GPs to work out an individuals' future risk of heart disease appear to overestimate the true risk by about 50%, according to research published in the British Medical Journal today. The research team, led by Dr Peter Brindle, a Bristol University researcher and city GP, also found that 84% of the coronary heart disease deaths that actually occurred during the study period, were in men predicted to be at low risk. Doctors base the decision to offer risk-reducing treatment, such as cholesterol and blood pressure-lowering drugs, on their patient's coronary 'risk'. If it is higher than it is in reality, it makes it difficult for both patients and doctors to make an informed choice about starting life-long treatment that may have side effects, requires regular monitoring and causes unnecessary anxiety. Current methods for assessing this risk are based on data collected between 1968-74 from Framingham, a small town in the north east of the USA. The relevance of the 'Framingham score' to the British population is uncertain. Dr Brindle and colleagues from London University, tested the accuracy of the Framingham coronary risk predictions in 6,643 men from the British regional heart study. They calculated each man's coronary risk and compared these predictions with the number of actual coronary events that occurred over ten years. During this ten-year period only 2.8% of men died from coronary heart disease, compared with the 4.1% predicted by the Framingham score - an overestimation of 47%. For fatal or non-fatal coronary heart disease events, such as a heart attack or angina, 10.2% occurred, compared with the 16% predicted - an overestimation of 57%. The authors also found that 84% of the coronary heart disease deaths occurred in the 93% of men classified as being at low risk (i.e. those that had a less than 30% chance of having a coronary event within 10 years). According to current guidelines this means they would be unlikely to have been offered cholesterol-lowering treatment. These findings have considerable implications for the prevention of coronary heart disease. The National Service Framework for coronary heart disease recommends the use of Framingham-based methods to identify high-risk people, and most people attending their GP for unrelated reasons are subject to this opportunistic screening. Dr Brindle said: 'While we acknowledge that performing a coronary risk assessment using the Framingham score, which takes into account up to eight different risk factors, is better than using purely clinical judgement, it is important that GPs and their patients understand the limits of the accuracy of the Framingham coronary risk score.' Bristol, University of |
|||||||||||||||||||||
| Related Heart Disease Current Events and Heart Disease News Articles Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." Carvedilol shown to have unique characteristics among beta blockers In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity. ESC to give talks on Diabetes in three cities in China As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most respected professional medical organisations in Europe, will be held from 27-29 November at three venues across China - Beijing, Shanghai and Guangzhou. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Drug for erectile dysfunction improves heart function in young heart-disease patients Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia. Study raises concerns about outdoor second-hand smoke Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard. Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep. Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. Heart and bone damage from low vitamin D tied to declines in sex hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. More Heart Disease Current Events and Heart Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||